See All Slides -

Slides

Presentation TCT 2012

Vincristine Local Delivery for Renal Artery Denervation

Presenter: Christodoulos Stefanadis

October 24, 2012

Presentation TCT 2012

PARTNER: Prognostic Value of Low Flow in Patients with Severe Aortic Stenosis

Presenter: Howard Herrmann

October 24, 2012

Presentation TCT 2012

Case 2: Management of Clotted Inferior Vena Cava Filter

Presenter: Mahmood Razavi

October 24, 2012

Presentation TCT 2012

Case 3: The Patient with a Recently Placed DES in Need of Emergent Major Surgery

Presenter: Harold Dauerman

October 24, 2012

Presentation TCT 2012

Mitral Valve Cerclage: Concept and Practicality

Presenter: Robert Lederman

October 24, 2012

Presentation TCT 2012

Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents)

Presenter: John Ormiston

October 24, 2012

Presentation TCT 2012

Utilization of Intravascular Ultrasound for Intralesional Rewiring in CTO: A Step-by-Step Approach

Presenter: Satoru Sumitsuji

October 24, 2012

Presentation TCT 2012

PCI of the Non-Infarct Vessel: Go or No-Go?

Presenter: John Bittl

October 24, 2012

Presentation TCT 2012

Management of Fibromuscular Dysplasia of the Carotid Artery

Presenter: Jeffrey Olin

October 24, 2012

Presentation TCT 2012

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presenter: Adnan Kastrati

October 24, 2012

Advertisement

Slides

Vincristine Local Delivery for Renal Artery Denervation

PARTNER: Prognostic Value of Low Flow in Patients with Severe Aortic Stenosis

Case 2: Management of Clotted Inferior Vena Cava Filter

Case 3: The Patient with a Recently Placed DES in Need of Emergent Major Surgery

Mitral Valve Cerclage: Concept and Practicality

Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents)

Utilization of Intravascular Ultrasound for Intralesional Rewiring in CTO: A Step-by-Step Approach

PCI of the Non-Infarct Vessel: Go or No-Go?

Management of Fibromuscular Dysplasia of the Carotid Artery

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content